Eupraxia Pharmaceuticals Inc.
NASDAQ:EPRXBiotechnology
Healthcare
$6.62 +1.11%
+$0.07 today
- Market cap
- $445.14M
- Beta
- 1.48
- P/E (TTM)
- -8.5
- EPS (TTM)
- -$0.74
52W Low $4.19High $9.32
Volume 1.64M
Average 0.22M
Price history
Eupraxia Pharmaceuticals Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+3.92%
Period high
$9.10
Period low
$5.81
Latest
$6.62
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| S-8 | Nov 12, 2026 | Nov 12, 2026 | |
| 6-K | Nov 10, 2026 | Nov 10, 2026 | |
| SUPPL | Nov 10, 2026 | Nov 10, 2026 | |
| 6-K | Nov 10, 2026 | Nov 10, 2026 | |
| 6-K | Nov 10, 2026 | Nov 10, 2026 | |
| 6-K | Nov 10, 2026 | Nov 10, 2026 | |
| 6-K | Oct 22, 2026 | Oct 22, 2026 | |
| 6-K | Oct 15, 2026 | Oct 15, 2026 | |
| 6-K | Oct 9, 2026 | Oct 9, 2026 | |
| 6-K | Sep 30, 2026 | Sep 30, 2026 | |
| 6-K | Sep 8, 2026 | Sep 8, 2026 | |
| SUPPL | Sep 2, 2026 | Sep 1, 2026 | |
| EFFECT | Aug 24, 2026 | Aug 25, 2026 | |
| F-10/A | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 |
Competitors
Who does Eupraxia Pharmaceuticals Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about EPRX's filings, answered from its disclosures.
What is the latest EPRX filing?
The latest filing shown is S-8 dated Nov 12, 2026.
How many recent filings does EPRX have?
Intrinsic Alpha currently shows 20 recent filings for EPRX.
Continue the stock analysis
Jump to another research area for this company.